Global Insulin Pump Market is estimated to reach US$ 64.75 Billion by 2027 from US$ 50.84 Billion in 2021 and is expanded to expand with a CAGR Of 5.18% During 2022-2027.
#insulin pen
EOFlow is seeking approval from the US Food and Drug Administration (FDA) for its wearable disposable insulin pump, EOPatch. The company has submitted a 510(k) application to the regulator for the disposable insulin pump to enter the US market. EOPatch insulin pump was launched in Korea in April last year.
#insulin pump
2022 represented a landmark year for next-generation diabetes tech. Here are the biggest stories from the past year. Some companies picked up major regulatory nods such as Dexcom and Senseonics. Others experienced major regulatory setbacks like Medtronic.
#insulin pump
#cgm
#closed loop
Health Canada has granted a licence to Medtronic Canada for the MiniMed 780G insulin pump system for use by type 1 diabetes patients.The device has been designed for the continuous delivery of basal insulin at selectable rates and amounts. With an advanced hybrid closed loop (AHCL), the MiniMed 780G system is claimed to be Canada’s first and only insulin pump to automatically adjust sugars every five minutes.
#cgm
#closed loop
#insulin pump
The report predicts the global insulin pumps market to grow with a CAGR of 14% over the forecast period from 2022-2028. The study on insulin pumps market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.
#insulin pump
Welldoc®, a digital health leader revolutionizing chronic care, today announced that Anand Iyer, PhD, MBA, Chief Analytics Officer of Welldoc, was recognized with the Global Innovator Award at the Global Digital Health Summit, Expo & Innovation Awards. Presented on October 29 in New Delhi, India, the Global Digital Health Innovation Awards honored leaders who are driving digital health innovation across healthcare.
Senseonics Holdings, Inc. and Ascensia Diabetes Care, exclusive distributor of Eversense® CGM Systems, today announced the launch of a collaboration with the Nurse Practitioner Group (NPG), a leader in multidisciplinary health services and medical staffing solutions. Senseonics, Ascensia and NPG view this collaboration as a scalable solution with the goal of expanding access to the Eversense E3 CGM System, enhancing the patient experience, streamlining the Eversense workflow for health care providers who elect not to do insertions themselves, thus broadening the universe of clinicians who prescribe Eversense.
#institution
#cgm
Precision medicine technology Zephyr AI has launched a partnership to further develop its artificial intelligence-enabled Insights product with MedStar Health, a healthcare provider in Maryland and the Washington, D.C., region. Initially focused on type 2 diabetes, the partnership will leverage MedStar Health’s T2D de-identified data sets and patient management expertise to refine Zephyr AI’s predictive analytics Insights product.
#r&d
Ascensia Diabetes Care has launched its online diabetes management and analytics platform GlucoContro.online in the United States. Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by enabling data-driven care for people using the CONTOUR® BGM portfolio. GlucoContro.online will be launched alongside CONTOUR®NEXT Concierge, Ascensia’s HCP-focused online platform for ordering CONTOUR meters and strips. With one login and within one uninterrupted system, HCPs will be able to rapidly access patient data as well as order essential supplies and samples from the CONTOUR® portfolio.
#bgm
#rpm
#mobile app
Bigfoot Biomedical today announced its Bigfoot Unity® Diabetes Management System is now compatible with four additional rapid-acting insulin products, including two unbranded biologics, from Eli Lilly and Novo Nordisk. All four insulin products are offered at a reduced price without compromising quality, helping to expand insulin access for people with diabetes.
#product & service